James A. Schoeneck - 21 Aug 2025 Form 4 Insider Report for Calidi Biotherapeutics, Inc. (CLDI)

Reporting relationship: Director
Issuer ticker: CLDI
Reported as of: 21 Aug 2025
Net transaction value: +$150,000
SEC form: 4
Accepted by SEC: 25 Aug 2025, 20:47:41 UTC
Prior SEC filing: 15 Jul 2025
Next SEC filing: 16 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Andrew Jackson, Attorney-in-fact

Key filing fact

James A. Schoeneck filed Form 4 for Calidi Biotherapeutics, Inc. (CLDI) on 25 Aug 2025.

Key facts

This page summarizes James A. Schoeneck's Form 4 filing for Calidi Biotherapeutics, Inc. (CLDI).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 25 Aug 2025, 20:47.

Change

Previous filing in this sequence was filed on 15 Jul 2025.
Current net transaction value: +$150,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001420987 Primary reporting owner

Schoeneck James A

Relationship: Director
Address: C/O CALIDI BIOTHERAPEUTICS, INC., 4475 EXECUTIVE DRIVE, SUITE 200, SAN DIEGO,
Signature: /s/ Andrew Jackson, Attorney-in-fact
Signature date: 25 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLDI transaction

Common Stock

Purchase

Transaction value: $150,000
Shares: +75,000
Change %: +6614%
Price: $2.00^*
Shares after: 76,134
Date: 21 Aug 2025
Ownership: Direct
Footnotes: F1, F2

CLDI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 347
Date: 21 Aug 2025
Ownership: Held with Spouse

CLDI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 8,033
Date: 21 Aug 2025
Ownership: By James & Cynthia Schoeneck Family Trust
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLDI transaction Derivative

Warrant (right to buy)

Purchase

Transaction value
Shares: +75,000
Change %
Price
Shares after: 75,000
Date: 21 Aug 2025
Ownership: Direct
Underlying class: Common stock
Underlying amount: 75,000
Exercise price: $2.00
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The common stock and warrants were acquired by the reporting person in a public offering conducted by the Issuer that was closed on August 21, 2025.

Footnote F2

Each common share was purchased with an accompanying warrant for a purchase price of $2.00 per share and accompanying warrant.

Footnote F3

The reporting person is a trustee of the James & Cynthia Schoeneck Family Trust. As such, the reporting person may be deemed to have shared voting, investment and dispositive power with respect to the shares held by the James & Cynthia Schoeneck Family Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shared for purposes of Section 16 or for any other purpose.

SEC remarks

Exhibit 24 - Power of Attorney (previously filed as Exhibit 24 to Form 4 dated April 22, 2024).